droxidopa has been researched along with Blepharoptosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Monnens, L | 1 |
Garland, EM; Joos, KM; Melson, MR; Phillips, L; Robertson, D | 1 |
Hirose, A; Karai, N; Kato, T; Katsube, J; Katsuyama, M; Nakamura, M | 1 |
3 other study(ies) available for droxidopa and Blepharoptosis
Article | Year |
---|---|
The cause of eyelid ptosis, orthostatic hypotension and exercise intolerance.
Topics: Autonomic Nervous System Diseases; Blepharoptosis; Dopamine beta-Hydroxylase; Droxidopa; Humans; Hypotension, Orthostatic; Norepinephrine | 2022 |
Pediatric ptosis as a sign of treatable autonomic dysfunction.
Topics: Adolescent; Anti-Inflammatory Agents; Arterial Pressure; Autonomic Nervous System Diseases; Blepharoptosis; Deamino Arginine Vasopressin; Diagnostic Techniques, Ophthalmological; Dopamine beta-Hydroxylase; Droxidopa; Female; Fludrocortisone; Humans; Intraocular Pressure; Male; Norepinephrine; Prospective Studies; Pupil; Young Adult | 2013 |
Reversal of the reserpine-induced ptosis by L-threo-3,4-dihydroxy-phenylserine (L-threo-DOPS), a (-)-norepinephrine precursor, and its potentiation by imipramine or nialamide.
Topics: Animals; Blepharoptosis; Brain Chemistry; Droxidopa; Drug Synergism; Imipramine; Injections, Intraventricular; Kinetics; Male; Mice; Nialamide; Norepinephrine; Reserpine; Serine | 1986 |